A quick roundup that touches on retatrutide alongside an anti-aging cream, a brain aging protein and a memory study in mice.
Recap by typeshit. Video by @taylorgarveyy on TikTok.
She describes MOTS-c as a messenger made by mitochondria that may help muscles handle sugar. The framing is hers and not an established health claim.
Medscape covers research tying GLP-1 drug use to lower alcohol consumption. Tap through for the study details and what researchers found.
In a small 2022 trial, whey beat leucine-boosted collagen for muscle growth, while evidence that collagen prevents sports injuries is still missing.
The orexin agonist, FDA approved in August, is being studied for ADHD and Parkinson's fatigue. Takeda's R&D head compares its reach to GLP-1 drugs, though data is early.
A busy week in Mexico also covered IMSS workers rejecting a 6.8% raise. GLP-1 drugs get a mention for shifting what people buy to eat.
Retatrutide is still in trials and not FDA approved, she notes, yet some college students are getting it from online sellers anyway.
Loading…